Page 3 - Alkem Laboratories
Alkem Lab jumps 4.5% as it launches Favipiravir drug to treat Covid-19
Alkem Laboratories has launched Favipiravir under the brand name 'Alfluenza' in India for the management of mild to moderate cases of Covid-19
 "Alkem Lab jumps 4.5% as it launches Favipiravir drug to treat Covid-19")
Antiviral drugs see demand surge in India, but segment declines 5.5%
Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April
 "Antiviral drugs see demand surge in India, but segment declines 5.5%")
Alkem Laboratories gets EIR from USFDA for manufacturing facility at Baddi
The USFDA has now issued an EIR for the manufacturing facility, it added.
 "Alkem Laboratories gets EIR from USFDA for manufacturing facility at Baddi")
CCI warns drugmakers not to indulge in unfair business practices
CCI said it has passed an order against the entities for violating provisions of the Competition Act by involving in anti-competitive business practices.
 "CCI warns drugmakers not to indulge in unfair business practices")
Alkem Labs hits record high, soars 8% on strong Q3 results, dividend bounty
The board of directors of the company has declared an interim dividend of Rs 22 per equity share for the financial year 2019-20.
 "Alkem Labs hits record high, soars 8% on strong Q3 results, dividend bounty")
Near-term overhang for Alkem Laboratories' fast growing US business
Any adverse outcome of the FDA's observations will impact the company's overall growth
 "Near-term overhang for Alkem Laboratories' fast growing US business")
Alkem Labs dips 11% as USFDA issues 13 observations for Daman facility
The stock dipped 11% to Rs 1,858 on the BSE in intra-day trade on back of heavy volumes.
 "Alkem Labs dips 11% as USFDA issues 13 observations for Daman facility")
Alkem Laboratories shares jump nearly 6%; m-cap up by Rs 15.23 billion
USFDA has issued an EIR for the company's manufacturing facility at Baddi, Himachal Pradesh, says Alkem Labs
 "Alkem Laboratories shares jump nearly 6%; m-cap up by Rs 15.23 billion")
Aklem Labs gets EIR from USFDA for Baddi facility; stock hits record high
The stock was up 5% at Rs 2,330 at 03:20 PM; after rallied 11% to Rs 2,468 on BSE in intra-day trade.
 "Aklem Labs gets EIR from USFDA for Baddi facility; stock hits record high")
Alkem Lab trades weak on three observations from USFDA for Baddi plant
The stock was down 2.3% at Rs 1,927 as compared to 1.72% rise in the S&P BSE Sensex at 11:09 am
Alkem Laboratories is grabbing the Street's eyeballs
Good momentum in domestic sales and growing US business help stock movement
 "Alkem Laboratories is grabbing the Street's eyeballs")
Alkem extends rally on good Q3 results
Thus far in the current calendar year 2017, the stock price has appreciated by 24% as compared to 6% rise in Sensex
Alkem Labs dips on USFDA observations on Ankleshwar API facility
The stock was down 5% to Rs 1,588 on the BSE.
Alkem Lab dips on US FDA observations on Daman plant
The stock dipped 8% to Rs 1,655 on the BSE in early morning trade.
 "Alkem Lab dips on US FDA observations on Daman plant")
Alkem Lab hits new high on USFDA clearance for Taloja facility
The stock was up 2% to Rs 1,625 on BSE, its highest level since listing in December last year.
Alkem Laboratories nears lowest level since listing
The stock dipped 7% to Rs 1,236 on the BSE in early morning trade.
Alkem changing systems after rap from regulator
European sales contribute less than one per cent of its total revenue, says drug maker
Alkem fudged trial data: German regulator
The European Medicines Agency's review is the second setback to Alkem Laboratories